Leontien Kremer’s Post

Meet Tara Anderson. She is one of four NIPANC supported PhD research students we are partnering with in collaboration with Queen's University Belfast. Their work helps us get a better understanding of #PancreaticCancer; how it impacts individuals and families in NI and provides insight into how we can continuously improve services and support for those impacted. The title of Tara’s PhD 'Exploring the Supportive Care Needs of Families Affected by Pancreatic Cancer: A Mixed-Methods Study' puts quality of life at the heart of Tara’s work, and she is asking for your support. She explained: “I am conducting a survey to gather information about the needs of those supporting someone with a pancreatic cancer diagnosis as well as the psychological impact that a loved one’s diagnosis may have. There could not be a better time to launch it than during NIPANC’s November #TimeMatters campaign during Pancreatic Cancer Awareness Month #PCAM.” This survey is open to everyone, aged 18+, who has a family member currently living with a pancreatic cancer diagnosis. This study has received ethical approval from the Faculty of Medicine, Health, and Life Sciences, QUB (Ref: MHLS 24_137) If you would like to participate, please follow this link to access the survey: https://lnkd.in/ehKgg5G2 Find out more about her important work here: https://lnkd.in/eiNmVaZn

Key Milestones of the STREXIT2 Project in 2024    As the year draws to a close, we are proud to reflect on the progress achieved in the STREXIT2 project:    Patient recruitment has officially begun, marking a critical milestone in the project. Currently, we are operating across 20 clinical sites in 10 countries, allowing for robust and diverse data collection.     An educational video was produced to deepen understanding of clinical studies in cancer research. It highlights the role of real-world evidence in STREXIT2 and underscores the importance of international collaboration in this multi-national European effort. Watch the video here: https://lnkd.in/d9vxyJTN   The STREXIT2 project was represented at multiple scientific conferences, including the Horizon Europe Cancer Mission's ‘Diagnosis and Treatment’ cluster meeting in Barcelona. These platforms provided opportunities to exchange insights, address shared challenges, and foster collaborations.    2024 has been a year of progress, learning, and strengthened partnerships. We would like to thank all collaborators and stakeholders and look forward to continuing this impactful journey in 2025.    #CancerResearch #STREXIT2 #EORTC #RetroperitonealSarcomas #MissionOnCancer #2024recap #STREXIT2_Horizon #HorizonEurope #EUCancerMission #SARCOMA #CancerResearch #ClinicalTrials #Cancer  #RetroperitonealSarcoma #SoftTissueSarcoma European Commission  EORTC - European Organisation for Research and Treatment of Cancer 

Earlier this year, the NCI Center for Cancer Health Equity (CCHE) established a new team of cancer researchers named the #CancerEquityLeaders. These individuals will come together under National Cancer Institute (NCI) leadership to advance health equity efforts in cancer care. “We wanted to initially focus our efforts on minority-serving institutions, which represent a rich resource of trainees, faculty, patients, and communities of need,” noted Sanya Springfield, PhD, Director of the NCI CCHE. “However, we made an observation on the other end of the professional ladder—the increase in diversity of our academic leaders and cancer center directors. We wanted to harness their collective expertise and acknowledge this positive moment in history.” The NCI recently revealed the three main objectives of the new group: 1. Assess the landscape to elucidate critical strengths and gaps in cancer equity infrastructure. 2. Prioritize the critical needs for expanding institutional capacity and achieving cancer health equity. 3. Develop a strategic agenda to enhance the #NationalCancerPlan. Read more here: https://lnkd.in/ddhJJUjN

UHN is expanding to meet the health care needs of the future! Today, we are excited to announce the purchase of 522 University Avenue. The 15-storey building will support the expansion of UHN programs in cancer care, research and education at UHN’s Princess Margaret Cancer Centre and Toronto General Hospital. The building will also serve as another important training ground for health care learners from UHN's Michener Institute of Education. “The demand for cancer diagnosis and treatment continues to surge here in Canada and around the world,” says UHN President and CEO Dr. Kevin Smith. "The addition of 522 University Avenue increases our capacity to drive innovation and research in cancer prevention, early cancer detection, diagnostics and treatment, as well enable the introduction of new and expanded programs at UHN.” Read the full release here: https://bit.ly/4ftIduI

🚀 The Belgian Cancer Registry (BCR) has a new website! Dive into our site to learn more about the vital work we do and access a wealth of information and resources. Here's what you can explore: 💠 Homepage: Stay updated with the latest news and discover key statistics on cancer diagnoses in Belgium. Access essential resources and tools. 💠 Registration: Learn about the data we record, including cancer diagnoses and screening data. Use our search function to explore specific registration projects. 💠 Figures & Publications: Access a comprehensive library of BCR publications, including cancer incidence, prevalence, survival statistics, and peer-reviewed articles. Utilize our updated drawing module for creating insightful visualizations. 💠 Screening: Discover BCR's role in organizing and evaluating regional cancer screening programs for breast, colorectal, and cervical cancer. Learn how we work to enhance the quality of population screening. 💠 Research: Explore ongoing and completed research projects that provide valuable insights into the impact of cancer on individuals and society. Additionally, learn about our mission, history, and team, and get answers to common questions. Visit our new website today and stay connected with BCR! 🔗 Explore the new BCR website: https://kankerregister.org #CancerResearch #HealthcareInnovation #BCR #DataDriven #PublicHealth #CancerAwareness #BelgianCancerRegistry

𝐖𝐨𝐫𝐥𝐝 𝐂𝐚𝐧𝐜𝐞𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐃𝐚𝐲   Today marks World Cancer Research Day, an excellent opportunity to acknowledge and recognise the life-changing cancer research that is conducted daily at Chris O’Brien Lifehouse (COBL). Research is at the heart of COBL, as we continue to develop new treatments and techniques, with the overall aim to improve cancer patient outcomes.   This year’s World Cancer Research Day theme is “Innovation In Cancer Research Drives Progress Toward Health Equity”. Innovations, such as early detection screenings, have allowed more people to access cancer care and prevention treatments, helping to achieve health equity worldwide.   COBL is significantly involved in cancer research and innovation, facilitated through the Chris O’Brien Lifehouse Research Institute. It is a multidisciplinary environment that allows innovators, researchers, and clinicians to work together to solve complex problems and advance cancer research.   Swipe through to learn about the research interests of COBL Research Faculty members A/Prof Kate Mahon, Dr Rebecca Venchiarutti and A/Prof Sanjay Warrier. Chris O'Brien Lifehouse Research Institute Integrated Prosthetics & Reconstruction #cobl #worldcancerresearchday #cancerresearch #research #innovation #choosehope #cancercare #chrisobrienlifehouse

🔬 We held our inaugural Victorian Paediatric Cancer Consortium Scientific Advisory Committees (SAC) meeting yesterday, cementing our commitment to scientific rigour. Esteemed national and international childhood cancer experts convened online to discuss critical areas of unmet need in childhood cancer research. Their advice will guide our funding priorities to accelerate childhood cancer research and innovation. Our two distinct SACs show our unique commitment to independent scientific expertise: 𝟭. 𝗧𝗵𝗲 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗮𝗻𝗱 𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗔𝗖, chaired by Board Director Andrew Wilks, focuses on translating discoveries into clinical applications. 𝟮. 𝗧𝗵𝗲 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗮𝗻𝗱 𝗛𝗲𝗮𝗹𝘁𝗵 𝗦𝗲𝗿𝘃𝗶𝗰𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗔𝗖, led by Board Director Grant McArthur AO, guides research on clinical trials and health services. Our SAC members include Phil Kearney, Martine Keenan, Deb White, Robyn Strong, Christopher Sweeney, Professor Tracey O'Brien, AM Martha Grootenhuis, Glenn Marshall and Brandon Wainwright AM. With our 8 consortium partners, we’re helping to fast-track paediatric oncology outcomes to benefit childhood cancer patients everywhere. #VPCC #ChildhoodCancerCare #ChildhoodCancer #CancerResearch #Collaboration #MakingADifference

Another major step towards defeating Cancer #cancer #research #healthcare #healthinnovation #artificialintelligence #torontohealthcare #discoverydistrict #healtheducation #topshospitals #canadahospitals #education #cancerresearch #cancertreatment

✨ Celebrating European Week Against Cancer ✨ This European Week Against Cancer, we’re uniting to raise awareness about cancer prevention, access to treatment, and support for patients and survivors. At the Federation of European Academies of Medicine (FEAM), we’re dedicated to promoting the importance of cancer screening for early detection and prevention. In 2022, we proudly released the report "Improving Cancer Screening in the European Union." This report is the result of initial scoping and exploratory work by FEAM on behalf of SAPEA (Science Advice for Policy by European Academies). The report plays a pivotal role in informing the Scientific Opinion of the Group of Chief Scientific Advisors, providing evidence-based insights that guide the European Commission and other policymakers. Join us in our mission to improve cancer screening across the European Union. Read the report and learn how we can work together to enhance early detection and save lives. 📰 https://bit.ly/3V4qTEq #EWAC2024 #EuropeanWeekAgainstCancer #CancerAwareness #CancerPrevention #FEAM #SAPEA #HealthMatters Scientific Advice Mechanism Stefan Constantinescu Antonio LOPRIENO Harry J de Koning

The 6th Annual European Cancer Forum is just ONE WEEK away! 🎉 Our CEO Antonella Cardone will join an incredible lineup of speakers to discuss “Navigating a Changing Cancer Care System” during Session III on 4 December 2024. This year’s theme, “Implementing a Sustainable Future for Cancer Care,” will focus on: 🏥 Optimizing patient pathways for early and effective care. 🔬 Expanding access to innovative screening and diagnostic technologies. 🤝 Showcasing learnings from best practices in early detection and multidisciplinary team care.   Registrations are still open: https://lnkd.in/eYP9ajnA   💭What measures do you think should be implemented to help cancer patients navigate the rapidly evolving cancer care system more effectively? Share your thoughts in the comments below! ⬇️ #EuropeanCancerForum #CancerCareInnovation #CollaborationForHealth #BeatingCancerPlan #FutureOfHealthcare #ECBP #EUCancerPlan #CancerPatientsEurope #CancerScreening #EarlyDetection #HealthEquity #HealthInequalities #EUHEalth #CancerAwareness #Oncology Jacki Davis Tuula Helander Martin Bailey Matias Olsen AI for Social Good EUCOPE - European Confederation of Pharmaceutical Entrepreneurs IHE - The Swedish Institute for Health Economics Digestive Cancers Europe MSD Europe European Oncology Nursing Society (EONS) European Parliamentary Forum Europa Uomo EU Make Sense Campaign Sosiaali- ja terveysministeriö European Commission European Parliament Council of the European Union